Literature DB >> 1653790

Mineralization ability of cultured human osteoblast-like periosteal cells does not decline with aging.

Y Koshihara1, M Hirano, M Kawamura, H Oda, S Higaki.   

Abstract

Studies of the mechanisms of osteoporosis have not yet determined whether these conditions result from increased osteoclast activity or decreased osteoblast activity, or perhaps both. Osteoporosis is related to aging and to postmenopausal status. The function and the mitotic capacity of cultured human osteoblast-like cells were investigated in this study. The age at which these cells lose the ability to divide showed a strong negative correlation with donor age (r = .815, p less than .01). There was also significant correlation of maximum cell saturation density with donor age (r = .698, p less than .01). Alkaline phosphatase (ALP) activity and mineralization ability, typical functions of osteoblasts, continue undiminished up to the point at which mitotic capacity ceases. When cells were treated with 1 alpha, 25-dihydroxy vitamin D3 in the presence of 2 mM alpha-glycerophosphate, ALP activity and mineralization ability showed an increase, rather than a decrease, with advancing donor age. However, these functions showed no correlation with in vitro cell aging. We propose that human osteoblast-like cells from elderly subjects do not lose their functions of mineralization and ALP formation, and that loss of these functions with cell aging does not correlate with advancing age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653790     DOI: 10.1093/geronj/46.5.b201

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  8 in total

1.  In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells.

Authors:  Claude Jaquiéry; Stefan Schaeren; Jian Farhadi; Pierre Mainil-Varlet; Christoph Kunz; Hans-Florian Zeilhofer; Michael Heberer; Ivan Martin
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

2.  Macrophage-lineage TRAP+ cells recruit periosteum-derived cells for periosteal osteogenesis and regeneration.

Authors:  Bo Gao; Ruoxian Deng; Yu Chai; Hao Chen; Bo Hu; Xiao Wang; Shouan Zhu; Yong Cao; Shuangfei Ni; Mei Wan; Liu Yang; Zhuojing Luo; Xu Cao
Journal:  J Clin Invest       Date:  2019-04-04       Impact factor: 14.808

3.  Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts.

Authors:  M Kassem; L Ankersen; E F Eriksen; B F Clark; S I Rattan
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Trabecular bone cell proliferation ex vivo increases with donor age in the rat: it is correlated with the extent of bone loss and not with histomorphometric indices of bone formation.

Authors:  D Egrise; A Vienne; D Martin; A Schoutens
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

5.  Age-dependent expression of osteoblastic phenotypic markers in normal human osteoblasts cultured long-term in the presence of dexamethasone.

Authors:  M S Sutherland; L G Rao; S A Muzaffar; J N Wylie; M M Wong; R J McBroom; T M Murray
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

6.  The use of rat, rabbit or human bone marrow derived cells for cytocompatibility evaluation of metallic elements.

Authors:  H Tomás; G S Carvalho; M H Fernandes; A P Freire; L M Abrantes
Journal:  J Mater Sci Mater Med       Date:  1997-04       Impact factor: 3.896

7.  In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls.

Authors:  M M Wong; L G Rao; H Ly; L Hamilton; S Ish-Shalom; W Sturtridge; J Tong; R McBroom; R G Josse; T M Murray
Journal:  Osteoporos Int       Date:  1994-01       Impact factor: 4.507

8.  Lrp5 is not required for the proliferative response of osteoblasts to strain but regulates proliferation and apoptosis in a cell autonomous manner.

Authors:  Behzad Javaheri; Andrew Sunters; Gul Zaman; Rosemary F L Suswillo; Leanne K Saxon; Lance E Lanyon; Joanna S Price
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.